Maze Therapeutics, Inc. 4

Paula A. Johnson received a stock option award for 36,000 shares of Maze Therapeutics, Inc. common stock at a $27.665 exercise price.

On August 13, 2026, Paula A. Johnson received a stock option award from Maze Therapeutics, Inc. for 36,000 shares of common stock at an exercise price of $27.665 per share, with no shares vested at grant. The option vests in 36 equal monthly installments beginning September 13, 2026, contingent on her continued service, and will expire on August 12, 2036. This is a compensatory option grant rather than an open-market purchase or sale, and following the grant she holds derivative securities representing rights to acquire 36,000 shares of Maze common stock.

Filing Facts

CIK

1842295

Ticker

MAZE

Form

4

Source Type

fda

Accession

0001341161-26-000005

Alert Tier

5